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1 
INTRODUCTION 
Diabetes is a Greek word - means "Siphon" ie., to pass through. 
Mellitus has the meaning of "honey", derived from Latin. Diabetes 
mellitus is a group of metabolic diseases characterised by hyperglycemia 
resulting from defects in insulin secretion, insulin action or both 1,2,3. 
Type 2 diabetes mellitus which was previously known as 
noninsulin dependent or maturity onset diabetes, is the commonest form 
of the disease, accounting for 85-95% of all cases worldwide and 
affecting 5-7% of the world's population4. 
Diabetes produces various acute and chronic complications. 
Diabetic ketoacidosis, hyperosmolar nonketotic hyperglycemia, lactic 
acidosis are important acute meabolic complications. Chronic 
complications include microvascular (neuropathy, nephropathy and 
retinopathy) and macrovascular (cerebrovascular accident, cardiovascular 
disease and peripheral vascular disease). 
Infection is a leading cause of hospitalisation among diabetic 
patients. Diabetes is associated with increased risk of developing 
infection5,6, increased severity of infection and prolonged hospital stay7,8. 
Urinary tract infection, respiratory tract infection and soft tissue infection 
are common infections with increased incidence in diabetes. Altered host 
defenses, vascular abnormalities, frequent hospital admissions are 
responsible for increased incidence. 
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Urinary tract being the prevalent infection site9,10, serious 
complications of urinary infection such as emphysematous cystitis, 
pyelonephritis, renal or perinephric abscess, bacteremia and renal 
papillary necrosis occur more commonly in diabetic patients11. 
Many urinary tract infections are asymptomatic and whether the 
symptomatic urinary tract infections are preceded by asymptomatic 
bacteriuria (ASB) is not known12,13. In contrast with men, development of 
ASB in diabetic women is much more common than in nondiabetic 
women9,12,13,14,15. Some investigators however, have been unable to 
confirm this findings16,17. 
Various risk factors for ASB in women with diabetes have been 
suggested including age, duration of diabetes, complications of diabetes 
13,14,15,18,19,20,21, glucosuria and pyuria22. 
Due to the importance of UTI complications, observed to a greater 
extent in diabetic patients and because renal involvement even without 
the presence of symptoms (example - subclinical pyelonephritis) is 
common23,24 investigating the association between ASB and symptomatic 
UTI in women with diabetes is important. 
Therefore it was determined to study ASB in type 2 diabetic 
women, since no published reports on this area is available from this part 
of the country. 
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AIMS OF THE STUDY 
• To find out the prevalence of Asymptomatic Bacteriuria in 
type 2 diabetic women. 
• To analyse the spectrum of organisms responsible for 
Asymptomatic Bacteriuria in this group and its antimicribial 
sensitivity pattern. 
• To correlate ASB with patient status (age, duration of diabetes, 
complications, etc). 
• To design an algorythm so as to identify and treat ASB in type 2 
diabetic women.  
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REVIEW OF LITERATURE 
DIABETES MELLITUS 
DEFINITION 
 Diabetes mellitus is a group of metabolic diseases charecterised by 
chronic hyperglycemia with disturbances of carbohydrate, fat, and protein 
metabolism resulting from defects in insulin secretion, insulin action or 
both1,2,3. 
HISTORY OF DIABETES MELLITUS24a 
 Polyuric states resembling diabetes mellitus have been described 
for over 3500 years. It was described in an Egyptian papyrus dating from 
1550 BC, discovered by Georg Ebers and a clearly recognisable 
description was given by Aretaeus of Cappadocia in the 2nd century AD. 
The term `diabetes' was first used by Aretaeus. The Hindu physicians, 
Charak and Sushrut, who wrote between 400 and 500 BC, were probably 
the first to recognise the sweetness of diabetic urine. The term `mellitus' 
was added by John Rollo in the late 18th century. 
 In 1776, Matthew Dobson concluded that diabetes was a  systemic 
condition, not a disease of the kidneys. The excess sugar in diabetes was 
identified as glucose by Chevreul in 1815. The role of pancreas was 
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demonstrated in 1889 by Oskar Minkowski and Josef Von Mering. 
Pancreatic `islets' was described in 1869 by Paul Langerhans. 
 Insulin was discovered at the University of Toronto in 1921 by 
Frederick Banting, Charles Best, Macleod and James Collip. The name 
`insulin' was coined by Macleod. Leonard Thompson was the first patient 
to receive insulin. 
EPIDEMIOLOGY 
 Prevalence of diabetes in adults worldwide was estimated to be 
4.0% in 1995 and to rise to 5.4% by the year 20254. It is higher in 
developed than in developing countries. The number of adults with 
diabetes in the world will rise from 135 million in 1995 to 300 million in 
the year 2025. The major part of this increase will occur in developing 
countries. There will be a 42% increase, from 51 to 71 million, in the 
developed countries and a 170% increase, from 84 to 228 million, in the 
developing countries. Thus, by the year 2025, >75% of people with 
diabetes will reside in developing countries, as compared with 62% in 
1995. 
 The countries with the largest number of people with diabetes are, 
and will be in the year 2025, India, China and the U.S. 
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 In India, estimated number of adults with diabetes was 19.4 million 
in 1995 and will be 57.2 million in 2025. According to WHO Ad Hoc 
Diabetes reporting group4, prevalence of diabetes in India was estimated 
to be 3.8% in 1995, 4.0% in 2000 and will be 6.0% in 2025. Prevalence 
of diabetes in Indian study (PODIS)25 showed that prevalence of type 2 
diabetes was found in 7.06% and Imparied fasting glucose (IFG) in 
7.87%. 
 Epidemilogical studies in India in the last decade have highlighted 
that not only is the prevalence of type 2 diabetes high, but that is 
increasing within the urban population. A recent survey showed that the 
prevalence of diabetes in urban adult was  12.1%.  Prevalence  of  
impaired  glucose  tolerance  was  also high  14.0%26.  Prevalence  of  
diabetes  was  found  to  be  lower  in  low socioeconomic group living in 
urban areas compared with the high income group (12.6% Vs 24.6% in 
subjects >  40 years). 
 Family history of diabetes, age, body mass index, waist:hip ratio, 
insulin resistance and sedentary life style showed positive association 
with diabetes in Indian populations. 
CLASSIFICATION 
 The majority of cases of diabetes fall into two broad 
etiopathogenetic categories, now called type 1 and type 2 diabetes. 
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Because of the increasing number of forms of diabetes for which a 
specific etiology can be recognised. The current clinical classification 
proposed by the American Diabetes Association (ADA) in 19971 and 
adopted by the World Health Organisation (WHO) in 199927 classifies 
diabetes according to etiology. 
 This classification differs from previous classification, which used 
the terms insulin dependent diabetes (IDDM), and non-insulin dependent 
diabetes (NIDDM). The terms type 1 and type 2 diabetes (with Arabic 
numerals) have been adopted for the most common forms of diabetes 
mellitus. 
Etiologic classification of diabetes mellitus 
I. Type 1 diabetes 
(β cell destruction, usually leading to absolute insulin deficiency). 
 A. Immune mediated 
 B. Idiopathic 
II. Type 2 Diabetes 
 (May range from predominantly insulin resistance with relative 
insulin deficiency to a predominantly secretory defect with insulin 
resistance). 
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III. Other specific types 
 A. Genetic defects of β cell function 
 B. Genetic defects in insulin action 
 C. Diseases of the exocrine pancreas 
 d. Endocrinopathies 
 E. Drug or chemical induced 
 F. Infections 
 G. Uncommon forms of immune mediated diabetes 
H. Other genetic syndromes sometimes associated with diabetes 
IV. Gestational Diabetes Mellitus (GDM) 
DIAGNOSTIC CRITERIA1,2 
 Three ways to diagnose diabetes are possible, and each, in the 
absence of unequivocal hyperglycemia, must be confirmed, on a 
subsequent day, by any one of the three methods. 
1. Symptoms of diabetes plus casual plasma glucose 
concentration > 200 mg/dl (11.1 mmol/L). Casual is defined 
as any time of day without regard to time since last meal. 
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The classic symptoms of diabetes include polyuria, 
polydipsia, and unexplained weight loss. 
(or) 
2. Fasting plasma glucose > 126 mg/dl (7.0 mmol/L). Fasting is 
defined as no caloric intake for atleast 8 hours.  
(or) 
3. 2 hour post load glucose > 200 mg/dl (11.1 mmol/L) during 
an OGTT. The test should be performed as described by 
WHO, using a glucose load containing the equivalent of 75g 
anhydrous glucose dissolved in water. 
TYPE 2 DIABETES MELLITUS 
Type 2 diabetes is the most common form of diabetes. It accounts 
for 85-95% of those with diabetes. It is characterised by disorders of 
insulin action and insulin secretion, either of which may be predominant 
feature. Usually, both are present at the time when diabetes becomes 
clinically manifest. Although the  specific  etiology is not known, 
autoimmune destruction of the β-cells does not occur. 
Patients with type 2 diabetes usually have insulin  resistance and 
relative, rather than absolute, insulin deficiency. At the time of diagnosis 
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of diabetes, and often throughout their lifetime, these patients do not need 
insulin treatment to survive, although ultimately many require it for 
glycemic control. This form of diabetes is associated with progressive 
β-cell failure with increasing duration of diabetes. Ketoacidosis seldom 
occurs spontaneously but can arise with stress associated with another 
illness such as infection. 
Most patients are obese and obesity aggravates the insulin 
resistance. Type 2 diabetes frequently goes undiagnosed for many years 
because the hyperglycemia develops gradually and in the earlier stages is 
not  severe enough to produce the classic symptoms of diabetes. However 
such patients are at increased risk of developing macrovascular and 
microvasular complications. Their circulating insulin levels  may be 
normal or elevated, yet  insufficient to control blood glucose levels within 
the normal range because of their insulin resistance. Thus, they have 
relative rather than absolute, insulinopenia. Insulin resistance may 
improve with weight reduction or pharmacological treatment and results 
in normalisation of their glycemia. 
Type 2 diabetes is seen frequently in women who have a previous 
history of gestational diabetes and in individuals with other 
characteristics of the insulin resistance syndrome, such as hypertension or 
dyslipidemia. 
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The risk of developing type 2 diabetes increases with age, obesity 
and physcial inactivity. Type 2 diabetes shows strong familial 
aggregation, so that persons with a parent or siblings with the disease are 
at increased risk. 
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ASYMPTOMATIC   BACTERIURIA 
 Asymptomatic bacteriuria is frequently detected in routine  
investigations. This is defined28 as > 105 cfu/ml organisms in the urine of 
apparently healthy asymptomatic patients. Approximately 1% of children 
under the age of 1, 1% of schoolgirls, 0.03% of school boys and men, 3% 
of non-pregnant adult women and 5% of pregnant women have 
asymptomatic bacteriuria. In females, asymptomatic bacteriuria increases 
upto 10% until an age of 65 years29. 
 There is no evidence that this condition causes renal scarring in 
adults who are not pregnant and have a normal  urinary tract. Upto 30% 
of patients will develop symptomatic infection within one year. The 
dilatation of the urinary tract during pregnancy allows bacteria to ascend 
easily to the kidneys. 
 Treatment of asymptomatic bacteriuria remains controversial. It 
has been proposed that transient  bacteriuria merely reflects colonisation 
of the bladder without tissue invasion, which clears spontaneously  and 
returns, or probably turns into true infection with pyuria over the time. 
 In general there is little evidence that routine treatment of positive  
cultures are required, except during pregnancy, children, patients for 
kidney transplantation and elderly bedridden patients. 
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PREVALENCE OF ASB IN DIABETES MELLITUS 
 Whether UTI and asymptomatic bacteriuria are more prevalent in 
diabetic women than in nondiabetic women has been debated for decades. 
More controlled studies have examined the prevalence of bacteriuria in 
diabetic compared with nondiabetic subjects than any other infection. 
 Kass30 in 1957 and several other investigators12,31-38 estimate that 
the prevalence of ASB is about 3 times higher in diabetic women 
(ranging from 15% to 25%) than in nodiabetic women (less than 10%). 
 One study15 that sampled diabetic (including those previously 
undiagnosed) and control nondiabetic subjects from a defined community 
found a higher bacteriuria prevalence associated with diabetes. These data 
therefore support a higher prevalence of bacteriuria in diabetic subjects. 
In some studies, however the reported prevalence of asymptomatic 
bacteriuria in diabetic women has been 10% or less14,38-40. 
PATHOGENESIS OF ASB  IN  DM 
1. Altered host defenses in diabetes  
(a) Innate cellular immunity 
 Several different immune deficits have been described in diabetics. 
Cell mediated immunity seems to be most affected, with abnormalities of 
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polymorphonuclear leucocytes (PMNLs), monocytes and lymphocytes 
reported. Numerous researchers have studied  PMNLs in the past, 
reporting abnormalities of adherence41,42, chemotaxis43,44,  phagocytosis45, 
oxidative burst46-49 and microbicidal ability48,50,51. All can improve with 
tighter glycemic control. 
 The intracellular killing of organisms by leucocytes is mediated by 
releasing of toxic free radicals, superoxides and hydrogen peroxide. This 
`respiratory burst' is defective in diabetes mellius. Diliamaire52 found 
significantly lower chemotaxis among both type 1 and type 2 diabetics 
and although there was an increased expression of certain adhesion 
molecules and evidence of spontaneous activation of PMNLs with 
increased free radical activation, the neutrophil response after stimulation 
was lower than in controls. 
 Gallacher et al53 found a significantly negative correlation between 
glycated hemoglobin levels and neutrophil bactericidal activity. The 
presence of advanced glycation end products leads to a state of low level 
persistant activation in PMNLs, as evidenced by increased concentration 
of neutrophil elastase, increased activity of neutrophil alkaline 
phosphatase and luminol dependent chemiluminescence and an increased 
rate of neutrophil oxygen consumption among unstimulated PMNLs of 
diabetic patients54,55. This hyperexited state leads to spontaneous 
activation of the oxidative burst and release of myeloperoxidase, elastase, 
and other neutrophil granule components that can be detrimental in two 
ways. 
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 1. May lead to a `burned out or tolerant' PMNLs that responds 
less vigorously  when stimulated by an infectious pathogen and 
 2. May initiate pathologic process leading to vascular injury, 
thus producing vascular complications. 
 Hyperglycemia and acidemia may both affect PMNL, function56, 
chemiluminescence studies have revealed improvement in phagocytic 
function with improved glycemic control45. Abnormalities in monocyte / 
macrophage chemotaxis and phagocytosis also have been reported. 
(b) Adaptive Cellular and Humoral Immunity 
 Adaptive humoral immunity in diabetics appears to be normal with 
normal levels of immunoglobulins and normal response to vaccination. 
Adaptive cellular immunity does appear to be affected57. 
(c) Complement 
 Hyperglycemia may result in defective complement mediated 
functions - for example, the defect in the opsonic binding site of the C3 
component of complement, increases susceptibility to candida infection58. 
2. Increased adherence of uropathogens to bladder epithelial cells 
 Researchers have sought to determine whether the increased 
adherence of  bacteria to uroepithelial cells in diabetic women is to blame 
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for the increased prevalence of UTIs and asymptomatic bacteriuria in this 
population. Recent studies59,60 shows that uropathogenic E.coli expressing 
type-1 fimbriae were twice as adherent to cells from women with diabetes 
as compared with cells collected from the women without diabetes. 
Uroepithelial cells from women with diabetes may have intrinsic 
differences in nature and/or amount and/or affinity of binding receptors 
for type -1 fimbriae. (Type-1 fimbriae - the virulence factor that plays an 
important role in the pathogenesis of UTIs.) 
3. "Sweet urine" Theory : The effects of glucosuria on the growth 
of uropathogens in diabetic persons 
High level of glucose in the urine of persons with diabetes might 
cause uropathogens to flourish. Geerlings and associates61 found that 
moderate and severe glucosuria (glucose concentration between 100 and 
1000 mg/dl) enhanced bacterial growth in vivo. Bacterial growth  in vitro 
was increased after the addition of different glucose concentration60. 
Murphy DP et al62 and Mohammed Ali Bouroumand et al22 observed a 
significant relationship between bacteriuria and glucosuria. These studies 
conclude that glucosuria may be one factor contributing to the increased 
prevalence of bacteriuria in diabetic persons. 
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4. Others 
Endothelial dysfunction, oxidative stress and the increased  
formation of advanced glycation end products  may play a role in the 
development of diabetic complications and also contribute to the 
development of infections63,64,65. Incomplete bladder emptying due to 
autonomic neuropathy permits urinary colonisation by 
microorganisms66,67. 
PATHOGENS IN DM 
For the most part, the same organisms cause UTI in diabetic 
patients as in nondiabetic patients. Escherichia coli in diabetic patients as 
in others, is the most common uropathogen. Other Enterobacteriacea 
(including Proteus, Klebsiella, Enterobacter and Citrobacter species), 
Pseudomonas aeruginosa, Enterococcus species, Streptococci, 
Staphylococci, Candida albicans  and other fungi have been reported. 
The percentage of infection with E.coli is lower in diabetic persons 
than non-diabetics31,68 and the percentage of infection with Klebsiella 
species is higher in diabetic persons than in those without diabetes68. In a 
few study microorganism was different. For example Klebsiella was the 
most common organism in the Alebiosu study69. 
Fungal UTIs caused by candida or Torulopsis slabrata are also 
more common in persons with diabetes than in those without9. 
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COMPLICATIONS 
Frequency of symptomatic urinary tract infections is higher among 
women with diabetes than among those without diabetes18,70. 
Furthermore, localisation studies have shown that infection of the upper 
urinary tract at initial testing is more common among women with 
bacteriuria and diabetes (occuring in 63 percent) than among women with 
bacteriuria but no diabetes (43 percent). Eighty percent of women with 
diabetes and bacteriuria have been shown to have renal parenchymal 
infection by seven weeks after initial testing23,36. 
An autopsy series documented a frequency of acute pyelonephritis 
among patients with diabetes that was four to five times as high as that 
among patients without diabetes71. The urinary tract is also a more 
common source of bacteremia among patients with diabetes5,70. 
Finally among women with diabetes, complicated symptomatic 
urinary tract infections are associated with higher frequencies of acute 
pyelonephritis, urosepsis and bilateral renal infection and a higher risk of 
hospitalisation than they are among nondiabetic women with 
symptomatic bacteriuria70,72. 
Other serious, although less common, complications of bacteriuria 
associated with diabetes include renal and perirenal abscesses, 
emphysematous cystitis, emphysematus pyelonephritis, renal papillary 
necrosis, fungal urinary tract infections and xanthogranulomatous 
pyelonephritis. 
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MANAGEMENT OF ASB 
 Diabetes mellitus with symptomatic bacteriuria is serious and 
warrants proper clinical attention for both diagnosis and treatment. 
Because of the frequent upper urinary tract infections and complications, 
most investigators recommend cultures for all urinary tract infections in 
patients with diabetes. Follow up urine culture after completion of 
antimicrobial therapy is also recommended for most women with diabetes 
in order to identify  patients in whom bacteriologic cure has not been 
achieved70. 
 Many  investigators70 have recommended screening patients with 
diabetes to detect and then treat asymptomatic bacteriuria because of the 
increased frequency and severity of upper urinary tract infections 
associated with symptomatic bateriuria in such patients, even though 
there are few data to support this recommendation. 
 Results from a study of women with diabetes who were treated for 
asymptomatic bacteriuria demonstrated no reduction in complications73. 
Although there were short term results in clearing bacteriuria with 
antimicrobial therapy, there was no decrease in the number of 
symptomatic episodes or hospitalisation over the long term. Furthermore, 
the high rate of recurrence of bacteriuria in those who were screened and 
treated, resulted in a marked increase in the use of antimicrobial agents. 
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Endre Ludwig et al74 recommend atleast one course of appropriate 
antibiotic therapy in an effort to eradicate the pathogen or  the postulated 
pathogen from the urinary tract, but this  is based solely on empiric 
evidence. 
Harding et al have been conducting a prospective study and 
preliminary data suggest a higher frequency of pyelonephritis and 
hospitalisation in women with untreated asymptomatic bacteriuria. These 
investigators stress, the importance of prophylactic antibiotic therapy. 
Fluroquinolones, betalactamase stable penicillins or cephalosporins 
are recommended antimicrobials for empiric therapy for ASB in diabetic 
patients. Recommended duration of treatment is 7 -10 days. 
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MATERIALS AND METHODS 
Setting 
 Outpatient sections of the Department of Diabetology and the 
Institute of Internal Medicine, Madras Medical College and Government 
General Hospital, Chennai - 3. 
Collaborating Departments 
 The Department of Diabetology and the Institute of Microbiology, 
Madras Medical College and Government General Hospital, Chennai-3. 
Study design  
 Single centre, cross sectional and analytical study. 
Period of study 
 The work was carried out from January 2006 to August 2006, 
continuously over a period of eight months. 
Inclusion criteria 
 Adult women with type 2 diabetes mellitus who gave voluntary 
consent were included. 
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Exclusion criteria 
Those who had one or combination of the following were 
excluded. 
¾ Symptoms of UTI - including dysuria, frequency, urgency, 
abdominal  discomfort, fever etc. 
¾  Vulvovaginitis 
¾  Pregnancy 
¾  Recent hospitalisation or surgery (<4 months) 
¾  Known urinary tract abnormalities (including cystopathy, etc.) 
¾  Recent urinary tract instrumentation (catheterisation, etc.) 
¾ Culture positive for three or more organisms, funguria 
¾  Use of antimicrobials in the last 14 days 
¾  Past history of UTI 
¾ Hypertension 
 Sample size 
  Study subjects: 238 type 2 diabetic women 
  Control subjects: 64 nondiabetic women 
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Consent 
 An informed consent was obtained from participants. 
Selection of study and control subjects 
Study subjects 
  Women with type 2 diabetes were recruited randomly from the 
outpatient section of the Institute of Internal Medicine and diabetes 
outpatient clinics of the Diabetology Department, Madras Medical 
College and Government  General Hospital. All are married and having 
children. They were treated with oral  hypoglycemic agents or insulin or 
both. All were normotensives. Initially 238 patients were selected, among 
them 74 were excluded (symptoms of UTI-11, vulvovaginitis-3, use of 
antimicrobials-2, past  history of UTI-28, culture positive for Candida 
albicans-4, culture positive for three or  more organisms-5 and 
hypertension - 21). 
 Control subjects 
  Women without diabetes were selected randomly from the general 
population.  They were relatives and friends of inpatients admitted in 
general medical ward. Exclusion crieteria  were the same as for diabetic 
women. Among them eight were excluded (positive UTI symptoms-4, 
hypertension - 2, use of antimicrobials-1 and culture positive for three or 
more organisms-1). 
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Details of study subjects 
  Their ages ranged from 31 to 80 years. All study subjects were 
interviewed during the first visit of the study and their medical history 
was obtained. This information included age, duration of diabetes, 
medications, complications of diabetes. The following laboratory data 
were included: fasting plasma glucose, blood urea, serum creatinine, 
albuminuria, glucosuria and leucocyturia. These patients were evaluated 
for microvascular and macrovascular complications of diabetes. Due to 
technical constraints practical concerns  HbA1C could not be done. Due to 
social concerns sexual history could not be obtained. 
 Details of control subjects 
  Their ages ranged from 32 to 76 years. All were interviewed and 
their non  diabetic status was confirmed by using 2 hour oral glucose 
tolerance test1,2. Agewise  distribution of control subjects were similar to 
study subjects. Laboratory data included were fasting plasma  glucose, 
blood urea, serum creatinine, albuminuria, glucosuria and leucocyturia. 
Definitions 
Diabetes mellitus 
  According to the American Diabetes Association Criteria1,2, a 
fasting plasma  glucose concentration of ≥7.0 mmol/L, a 2 hour 
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(post glucose) plasma glucose  concentration of ≥ 11.1 mmol/L or the use 
of glucose lowering medications (oral agents  or insulin). 
Asymptomatic bacteriuria 
  Asymptomatic bacteriuria is defined as the presence of atleast 105 
colony forming  units/ml of 1 or 2 bacterial species in clear voided 
midstream urine sample from an individual without symptoms of urinary 
tract infection28. 
  Presence of atleast 3 microorganisms in one urine specimen was 
considered as contaminated urine and these specimens were excluded. 
Cultures positive for Candida  species were not considered as positive 
because this study was confined to bacteriuria.  
Glucosuria and proteinuria 
 Glucosuria  and proteinuria were defined as any level of glucose or 
protein, respectively, above  a trace level on urine analysis. 
Leucocyturia (Pyuria) 
 Leucocyturia is defined as more than five leucocytes per high 
power field. 
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Urinary samples  
 Each individual was explained on the technique of urine collection. 
Midstream clean voiding urine specimens were collected in a wide 
mouthed sterile container for the  evaluation of bacteriuria. All urine 
samples were immediately sent to Microbiology  laboratory and were 
cultured. Urine culture was performed according to standard  procedure. 
All urine samples were cultured on Cystein Lactose Electrolyte Deficient 
(CLED) agar. Antibiotic sensitivity was tested by using Muller-Hinton 
agar plate by  Kirby Baur's disc diffusion method. Ciprofloxacin, 
Ofloxacin, Amikacin, Gentamicin, Penicillin-G, Cefotaxime and 
Cefaperazone sulbactum were the drugs used, as they were used in this 
hospital at the time of study. Instead of Penicillin-G, Oxacillin was used 
for Enterococci. 
 Glucosuria and proteinuria were assessed by using Benedict's 
method and Turbudimetric method respectively. 
Conflict of interest 
 There was no conflict of interest. 
Financial support 
 This work was not supported by any funding agency or charitable 
organisation. 
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Statistical analysis  
 Differences between patients with and  without ASB were obtained 
through  
`t test' for continuous variables (age, duration of  diabetes, urea, 
creatinine). For nominal variables `Chi-Squared test' was used. In 
addition, by using leucocyte as a dependent variable and age, duration of 
diabetes, nephropathy, neuropathy, ischemic heart disease as independent 
variables, multiple logistical regression analysis was used. Data were 
analysed by SPSS statistical software and P value of <0.05 was 
considered significant. Mean values are reported as mean ± standard  
deviation. 
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RESULTS 
 There was 164 participants in the study group and 56 nondiabetic  
women in the control group. Their characteristics are provided below in 
Table 1 and Table 2 respectively. 
Table 1: Characteristics of study group 
Characteristics Median Mean ± SD 
 Age (years) 52.0 52.4 ± 11.2 
 Duration of diabetes (years) 5.0 6.3 ± 4.5 
 Plasma glucose (mmol/L) 7.2 7.9 ± 3.1 
 Blood urea (mmol/L) 3.6 3.7 ± 0.8 
 Serum creatinine (µmo1/L) 88.0 87.2 ± 29.0 
 
Table 2: Characteristics of control group 
Characteristics Median Mean ± SD 
 Age (years) 50.0 51.1 ± 11.8 
 Plasma glucose (mmol/L) 4.6 4.6 ± 0.6 
 Blood urea (mmol/L) 3.5 3.5 ± 0.2 
 Serum creatinine (µmo1/L) 71.0 74.3 ± 10.5 
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 Study group ages ranged from 31 to 80 years with a mean of 
52.4 ± 11.2 and median of 52 years. Duration of diabetes in this group 
was between 1 to 20 years with a mean of 6.3 ± 4.5 and median of 5 
years. Mean values of plasma glucose, blood urea and serum creatinine 
were 7.9 ± 3.1, 3.7 ± 0.8 mmol/L and 87.2 ± 29.0 µmol/L respectively. 
 Control group ages ranged from 32 to 76 years with a mean of 
51.1 ± 11.8 and median of 50 years. Mean values of plasma glucose, 
blood urea and serum creatinine were 4.6 ± 0.6, 3.5 ± 0.2 mmol/L and 
74.3 ± 10.5 µmol/L respectively. 
 Age wise distribution of the individuals belonging to study group 
and control group is given in Table 3 and Table 4 respectively. Majority 
of study subjects belonged to age group 51 to 60 which was followed by 
41 to 50 years.  
 Table 3: Study group-Age wise distribution 
Age  (years) Number (164) Percentage 
30-40 30 18.3 
41-50 46 28.0 
51-60 53 32.3 
>60 35 21.3 
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 Table 4: Control group-Age wise distribution 
Age  (years) Number (56) Percentage  
30-40 12 21.4 
41-50 17 30.4 
51-60 16 28.6 
 >60 11 19.6 
  
 Majority of control subjects were belonged to age group 41 to 50 
which was followed by 51 to 60 years. 
 Based on the duration of diabetes, study group was further 
subdivided into 3 groups as shown in Table 5. Most of them (79.8%) 
were less than 10 years of duration.  
 Table 5: Study group-duration of diabetes 
Duration of  diabetes 
(years) 
Number (164) Percentage 
 <5 74 45.1 
 5-10 57 34.7 
 >10 33 20.1 
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  Micro and macrovascular complications of the study group are 
provided in Table 6 given below. Among them, neuropathy, retinopathy 
and cardiovascular complications were observed in 24.3, 19.5 and 9.1% 
respectively. 
Table 6: Study group-Micro and Macrovascular complications 
 Complications Number 
(164) 
Percentage 
 Microvascular   
 Retinopathy 32 19.5 
 Nephropathy 11 6.7 
 Neuropathy 40 24.3 
 Macrovascular   
 Cardiovascular system (CVS) 15 9.1 
Central nervous system (CNS) 3 1.8 
Peripheral vascular disease (PVD) 5 3.0 
  
 Among the study subjects proteinuria, glucosuria and leucocyturia 
were observed in 18.3, 24.4 and 20.1% respectively and the details as 
depicted in Table 7. 
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Table 7: Urine analysis - study subjects 
 Urine analysis Number (164) Percentage 
 Proteinuria 30 18.3 
 Glucosuria 41 24.4 
 Leucocyturia 33 20.1 
  
 Urine culture was positive in 37 participants in the study group and 
three participants in the control group which are provided in Table 8, 
eventhough they were asymptomatic. 
Table 8: Prevalence of asymptomatic bacteriuria (ASB) 
Subjects Number (ASB positive 
subjects) 
Percentage 
 Study group (n=164) 37* 22.56 
 Control group (n=56) 3 5.36 
 
ASB - Asymptomatic bacteriuria  *Significant (p<0.001) 
 Overall the prevalence of ASB was 22.56% in study group and 
5.36% in control group. Analysis of the prevalence of ASB among study 
group and control group by Chi-Square test revealed that, ASB was 
significantly more among diabetes than control. 
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 Characteristics of study subjects those with asymptomatic 
bacteriuria are shown in table 9, provided below.  
Table 9: Characteristics of ASB positive study subjects 
ASB positive study 
subjects (n=37) 
Number Percentage 
Age group (years)   
30-40 6 16.2 
41-50 11 29.7 
51-60 16 43.2 
>60  4 10.8 
Duration of diabetes 
(years) 
  
<5  17 45.9 
5-10  12 32.4 
>10  8 21.6 
Complications of diabetes   
Retinopathy 9 24.3 
Nephropathy 8 21.6 
Neuropathy 6 16.2 
CVS  4 10.8 
CNS  1 2.7 
PVD  Nil - 
Urine analysis   
Glucosuria  19 51.3 
Proteinuria  26 70.0 
Leucocyturia  24 64.8 
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Among patients with bacteriuria (n=37), six (16.2%) were under 41 
years old. Of study subjects between 41 to 50, 51 to 60 and more than 60 
years 23.6, 30.1 and 11.4% had bacteriuria respectively. 
Among patients with less than 5 years of diabetes 22.9% and 
patients with 5 to 10 years of diabetic history 21.0% had bacteriuria. 
Among the 33 patients who had diabetes of more than 10 years duration, 
24.2% had bacteriuria. 
Of the 37 patients who had positive urine culture, 70% had 
proteinuria. Among 41 study subjects with proteinuria, 63.4% had 
bacteriuria as well. 
In this study, 64.8% of patients with bacteriuria also displayed 
leucocyturia and 92.9% of participants without bacteriuria showed no 
evidence of leucocyturia. Among patients with bacteriuria, 51.3% had 
glucosuria and patients without bacteriuria, 91.3% had no glucosuria. 
Among the glucosuria and leucocyturia positive study subjects, 63.3 and 
72.7% had bacteriuria respectively. 
Among the ASB positive study subjects, retinopathy, nephropathy, 
neuropathy, cardiovascular complications and cerebrovascular disease 
were observed in 24.3, 21.6, 16.2, 10.8 and 2.7% respectively. None of 
them had peripheral vascular disease. 
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The isolates (microorganisms) from urine cultures of both diabetic 
and nondiabetic women during the study period is provided in Table 10 
given below. 
Table 10: Microorganisms isolated 
 Microorganisms Number Percentage 
 Study subjects (n=37)   
 Escherichia coli 17 45.9 
 Klebsiella 10 27.0 
 Coagulase negative staphylococci 4 10.8 
 Staphylococcus aureus 5 13.5 
 Enterococci 1 2.7 
 Control subjects (n=3)   
 Escherichia coli 2 66.6 
 Klebsiella 1 33.3 
   
The nature of the microbial isolates and its sensitivity as well as 
resistant pattern is shown in table 11. 
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Table 11: Microorganisms and its sensitivity pattern 
 Organisms Ciprofloxacin Ofloxacin Amikacin Gentamicin Penicillin-G Cefotaxime Cefoperazone 
sulbactum 
 E.coli (n=17) 
 Sensitive 7 7 17 13 NT 10 17 
 Resistant 10 10 0 4 NT 7 0 
 Klebsiella (n=10) 
 Sensitive 7 7 10 7 NT 6 10 
 Resistant 3 3 0 3 NT 4 0 
 Coagulase negative  staphylococci (n=4) 
 Sensitive 1 4 4 NT 2 2 4 
 Resistant 3 0 0 NT 2 2 0 
 Staphylococcus aureus (n=5) 
 Sensitive 1 2 5 NT 0 2 4 
 Resistant 4 3 0 NT 5 3 1 
 Enterococci (n=1) 
 Sensitive 1 1 1 NT 0 0 1 
 Resistant 0 0 0 NT 1* 1 0 
 
NT-Not tested     * Oxacillin used 
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The association of asymptomatic bacteriuria was statistically 
analysed with age, duration of diabetes, micro and macrovascular 
complications of diabetes, blood biochemistry, glucosuria,  proteinuria 
and leucocyturia. The association of leucocyturia with nephropathy, 
neuropathy and cardiovascular complications were also statistically 
analysed. Among them proteinuria, glucosuria, leucocyturia, 
nephropathy, plasma glucose and serum creatinine, had significant 
association with asymptomatic bacteriuria, but patients age, duration of 
diabetes, retinopathy, neuropathy and macrovascular complications were 
not. Their P values are given in Table 13 (next page). 
Sensitivity, specificity, positive predictive value and negative 
predictive value of leucocyturia with reference to asymptomatic 
bacteriuria was 64.8, 92.9, 72.7 and 90.0% respectively shown in  
Table 12. 
Table - 12 
 ASB present ASB absent Total 
Leucocyturia present 24 9 33 
Leucocyturia absent 13 118 131 
Total 37 127 164 
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Table 13: Asymptomatic bacteriuria in relation to characteristics 
Variables P value 
 ASB and age 0.22060NS 
 ASB and duration of diabetes 0.93481NS 
 ASB and retinopathy 0.40128NS 
 ASB and nephropathy <0.001** 
 ASB and neuropathy 0.37849NS 
 ASB and CVS complications 0.68981NS 
 ASB and CNS complications 0.65233NS 
 ASB and PVD 0.22029NS 
 ASB and plasma glucose 0.00439** 
 ASB and serum creatinine 0.00074** 
 ASB and proteinuria <0.001** 
 ASB and glucosuria <0.001** 
 ASB and leucocyturia <0.001** 
 Leucocyturia and nephropathy <0.001** 
 Leucocyturia and neuropathy 0.93999NS 
 Leucocyturia and CVS complications 0.88113NS 
  ** Significant at 1%  level  NS-Not significant 
ASB-Asymptomatic bacteriuria  CVS-Cardiovascular system  
CNS-Central nervous system   PVD-Peripheral vascular disease  
 Multiple logistical analysis was also applied. In this analysis 
leucocyte was used as a dependent variable. It was analysed with 
independent variables such as age, duration of diabetes, nephropathy, 
neuropathy and cardiovascular complications. Asymptomatic bacteriuria 
was statistically noticed more among those with nephropathy.  
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DISCUSSION 
  Asymptomatic bacteriuria in diabetes mellitus should be 
considered and looked for while diabetic patients come for review. In this 
study 37 out of 164 type 2 diabetic women had asymptomatic bacteriuria 
and the prevalence of ASB was 22.56%. This is comparable with earlier 
studies by Alebiosu et al.10  which was  26.6%; Joffe et al.35, Kass et al.32 
and Hansen et al.33 noticed ASB in 20, 18 and 18.5% respectively. 
Similaly Vejlsgaard et al.12, and O'sullivan et al.38 observed 18.8% and 
19.8% of bacteriuria respectively. But more prevalence of ASB in 
diabetic women was reported in Geerlings et al.31 study [both type 1 and 
type  2 diabetic patients -26% (163 of 636); type 2 diabetic patients - 29%  
(110 of 378)]. Jaspan et  al.37 reported 27% bacteriuria in diabetic 
patients. 
   Bahl et al.34, 11.3%; Ooi BS et al.36, 15.8%; and Mohammed Ali 
Boromand et al.22, 10.6% studies showed increase in prevalence of ASB 
in diabetic women. Zhanel et al.18, 7.9% (85 of 1072); Sawers et al.20, 
9.5% (38 of 400); and Schmitt et al.14, 9.1% reported high prevalence of 
bacteriuria in   diabetic women. 
   All these studies were shown 2 to 4 fold increase in prevalence of 
ASB in   diabetic women than nondiabetic women. Some of the 
publications did not notice any difference in prevalence of bacteriuria 
between diabetic and nondiabetic men. Table 14 shows the various 
studies and prevalence of bacteriuria in diabetic population. These studies 
have been recently summarised and published75. 
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TABLE - 14 
STUDIES ON THE ASSOCIATION BETWEEN DIABETES AND BACTERIURIA 
Subjects (n) Prevalence (%)  Outcome  
definition Diabetic Nondiabetic Diabetic Nondiabetic 
Adjustment  
factors 
Author 
Asymptomatic bacteriuria F= 54 
M =37 
F=337 
M=102 
F=18.0 
M=5.0 
F=6.0 
M=4.0 
None Kass EH32 
Asymptomatic bacteriuria F= 81  
M =67 
F= 81  
M =67 
F= 18.5 
M =7.5 
F= 7.5 
M =3.0 
Age and sex 
matched 
Hansen RO33 
Asymptomatic bacteriuria F=97 
M-149 
n=100 
Sex not specified 
F=11.3 
M=10.7 
M& F = 3.0 None Bahl et al.34 
Asymptomatic bacteriuria F=60 F=36 F=20 F=2.8 None Joffe et al.35 
Asymptomatic bacteriuria F=152 
M=154 
F=152 
M=159 
F=15.8 
M=1.3 
F=4.6 
M=0.7 
Matched on age 
sex and parity 
Ooi BS et al.36 
Asymptomatic bacteriuria Both type1 and type 2 
diabetes F=636 
 
 
Type 2 diabetes F=378 
 
 
F=153 
Both type 1 and 
type 2 diabetes 
F=26 
 
Type 2 diabetes 
F=29  
 
 
F=6 
 
 
None 
Geerlings et al.31 
Asymptomatic bacteriuria F=202 - F=10.6 - - Mohammed et 
al.22 
 
(Continued next page) 
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TABLE - 14 (Continued) 
STUDIES ON THE ASSOCIATION BETWEEN DIABETES AND BACTERIURIA 
Subjects (n) Prevalence (%) Outcome  
definition Diabetic Nondiabetic Diabetic Nondiabetic 
Adjustment  
factors 
Author 
Bacteriuria F=128 
M=141 
F=114 
M=146 
F=18.8 
M=0.7 
F=7.9 
M=2.1 
Similar age to 
sex distribution 
Vejlsgaard R12 
Bacteriuria F=111 
M=87 
F=79 
M=68 
F=27.0 
M=8.0 
F=11.4 
M=2.9 
None Jaspan et al.37 
Bacteriuria F=341 
M=411 
F=100 
M=100 
F=9.1 
M=1.0 
F=5.0 
M=0 
None Schmitt et al.14 
Bacteriuria F=91 
M=59 
F=91 
M=59 
F=19.8 
M=3.3 
F=18.7 
M=1.7 
Similar age and 
sex distribution 
O' Sullivan et 
al.38 
Chemstrip LN n=206 
sex not specified 
n=41 
sex not specified 
M&F = 5.8 M&F=1.7 Age, ethnicity, 
sex, country of 
residence 
Keane et al.15 
Asymptomatic bacteriuria F=47 
M=53 
F=48 
M=52 
F=10.6 
M=3.8 
F=8.3 
M=1.9 
Age and sex 
matched 
Vigg et al.39 
Asymptomatic bacteriuria F=100 
M=90 
F=100 
M=90 
F=9.0 
M=3.3 
F=8.0 
M=2.5 
Matched on age 
by decade and 
sex 
Abu-Bakare et 
al.40 
Asymptomatic bacteriuria F=164 F=56 F=22.5 F=5.3 Age matched Present study 
M = Male   F = Female  n = number  Source = Boyko et al.75 
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Like most other earlier studies, here also Escherichia coli was the 
most prevalent microorganism (45.9%) isolated from urine culture. In 
control group three subjects had positive urine culture, out of which two 
were E.coli. Lye et al.68, observed that E.coli was the predominant 
microorganism in UTIs in diabetic patients, but E.coli occurs in 
significantly lower numbers than in control subjects, similar to the 
present study. 
   In a few studies the microorganisms were different. For example 
Klebsiella   was the most common organism in the Alebiosu study69. In 
this study, Klebsiella is the second common organism (27%). Coagulase 
negative staphylococci (10.8%), Staphylococcus aureus (13.5%) and 
Enterococci (2.7%) are the other organisms isolated in this study group. 
   As in Table 11 (Page 36), most of the E.coli strains were sensitive 
to Amikacin, Gentamicin and Cefoperazone sulbactum. About half of 
them were resistant to Ciprofloxacin, Ofloxacin and Cefotaxime. 
   All Klebsiella strains were sensitive to Amikacin and Cefoperazone   
sulbactum. Approximately 30% of them resistant to Ciprofloxacin, 
Ofloxacin,   Gentamicin and Cefotoxime. 
   Most of the Coagulase negative staphylococci were resistant to   
Ciprofloxacin and approximately 50% were resistant to Penicillin-G and 
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Cefotaxime. All of them were sensitive to Ofloxacin, Amikacin and 
Cefoperazone sulbactum. 
  Amikacin and Cefoperazone sulbactum were highly sensitive drugs 
for Staphylococcus aureus. Most of them were resistant to Ciprofloxacin, 
Ofloxacin and Cefotaxime. 
   Enterococci was sensitive to Ciprofloxacin, Ofloxacin, Amikacin 
and Cefoperazone sulbactum. This organism was resistant to Penicillin-G 
and Cefotaxime. 
Sensitivity to the drugs like Ciprofloxacin, Ofloxacin, Gentamicin 
and Cefotaxime was declining. Frequent usage may be the attributable 
reason. However, most of the organisms were sensitive to Amikacin and 
Cefoperazone sulbactum. Further studies in this regard must be 
accomplished and the results  should be compared with the antibiograms 
of nondiabetic patients. 
Statistical analysis revealed a highly significant relationship 
between bacteriuria and leucocyturia (p<0.001). Mohammed Ali 
Boroumand et al.22 reported that pyuria (leucocyturia) and glucosuria had 
a significant relationship with bacteriuria. Geerlings et al.31, 76 found that 
macroalbuminuria was a risk for developing ASB. Macroalbuminuria as 
an expression of severe structural damage in the kidney, may increase the 
vulnerability to bacterial attacks, thus resulting in an increased risk of 
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developing ASB. In the present study significant (p<0.001) association 
between bacteriuria and proteinuria, bacteriuria and glucosuria were also 
noticed. 
In this study, bacteriuria had a significant association with 
nephropathy (p<0.001) and elevated serum creatinine (p<0.001). Altered 
host defence mechanism in diabetes may be aggravated by development 
of nephropathy in diabetic patients and inturn it increases the prevalence 
of ASB. Some studies14,18 showed  that the presence of long standing 
complications (peripheral neuropathy, peripheral vascular disease) 
increased the risk of developing ASB. But here, except nephropathy, no 
other diabetic complications had significant association with ASB. 
Some studies had shown31,76 that glycemic control had no 
association with ASB. But here, ASB had significant association with 
fasting plasma glucose levels, but this may be unreliable because, plasma 
glucose levels highly variable with drugs (oral hypoglycemic agents or 
insulin), dietary intake and physical activity. 
Eventhough age is a well known risk factor for bacteriuria in 
women without diabetes77 and some studies have shown age as the most 
important risk factor for ASB in type 2 diabetic patients31. However, age 
had no significant relation with ASB in this study (p=0.2206). Most of the 
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earlier studies did not show any increase in the incidence of ASB in 
elderly population with diabetes12, 14, 18, 19. 
Some studies have shown that a longer duration of diabetes 
increases the risk of developing ASB14, 18, while others could not confirm 
this notion13, 16, 19. In this study, duration of the disease was independent 
of ASB (p=0.9348). 
Overall risk factors for ASB in type 2 diabetic women observed in 
the present study are provided in Table 15 below. 
Table 15: Risk factors for women with type 2 diabetes 
Risk factors P value 
Proteinuria <0.001 
Leucocyturia <0.001 
Glucosuria <0.001 
Nephropathy <0.001 
Plasma glucose 0.0044 
 
 Considering these risk factors, blood glucose is a highly variable 
factor, which depends on dietary intake, physical activity and regularity 
of treatment. Renal threshold to glucose is variable in different 
individuals and also in the same individual at different times. Hence 
glucosuria can not be considered as a sole criteria. Diabetic nephropathy 
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per se manifest as a proteinuric state and serum creatinine does not rise 
until more than 50% of GFR has been lost. At primary health care level 
early diagnosis and confirmation of nephropathy is not feasible till 
proteinuria becomes overt. Eventhough glucosuria, proteinuria and 
nephropathy were significantly associated with asymptomatic bacteriuria, 
at primary care level the applicability is variable. 
 To test urine culture and sensitivity, adequate lab facilities are 
required. This is not available in a primary health care level but only 
available in Medical Colleges and Head Quarters hospitals. 
 Since leucocyturia had a significant association with ASB 
(p<0.001), this test can be used as a simple and cost effective screening 
test in a primary health care level. Positive cases can be sent to higher 
centres for urine culture and sensitivity. 
 Based on the availability and accessibility at rural level, an 
algorythm has been developed, to assess and manage asymptomatic 
bacteriuria in diabetic women. 
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Algorythm to detect and manage ASB in Type - 2 Diabetic Women
Diabetes Mellitus
Urine microscopy
> 5 leucocytes / HPF < 5 leucocytes / HPF
Urine culture & sensitivity Symptoms No symptoms
No Treatment
(empirical antibiotic)
Positive urine culture Negative urine
culture
No symptoms Symptoms No symptoms
No risk factors Risk factors
*  Urinary tract abnormalities
*   Autonomic neuropathy
*   Nephropathy
*   Elderly
*  Pregnancy
Repeat Urine C/S
Negative Positive
GramStain,
Acid fast bacilli
Urethrall  swab Treatment
Annual
follow-up
Negative
Positive
Follow-up
No Treatment
Annual
follow-up
 
 
 
48
Strength of the study 
 Rigid criteria for case selection, meticulous efforts to collect urine 
samples for microbiological study and comparability of the observation 
with previous reports make the study strong. Based on the study one can 
confidently consider asymptomatic bacteriuria in diabetic women if she 
has leucocyturia. 
Limitations 
 Hb A1c was not estimated. 
  Details of sexual habits and sexual hygiene were not elicited. 
Suggestions 
 Prospective studies on follow-up of cases to asymptomatic 
bacteriuria in the clinical course and complications of diabetes will help 
us to decide the effect of asymptomatic bacteriuria and its metabolites on 
diabetes in order to arrive valid conclusion regarding treatment of these 
cases. 
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CONCLUSION 
• The prevalence of asymptomatic bacteriuria in type 2 diabetic 
women was 22.56% and comparable with published reports. 
• Asymptomatic bacteriuria was independent of age and duration of 
diabetes. 
• Asymptomatic bacteriuria was significantly more among diabetics 
with nephropathy. 
• Simple bedside method to screen asymptomatic bacteriuria is 
leucocyturia and it has a positive predictability (72.7%) to detect 
bacterial isolates. 
• Among asymptomatic bacteriuria, gram negative isolates were 
greater than gram positive ones. 
• Isolates were resistant to most of the commonly used 
antimicrobials (Ciprofloxacin, Ofloxacin, Gentamicin and 
Cefotaxime) in clinical practice. 
• An algorythmic approach to find out asymptomatic bacteriuria has 
been designed. 
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SUMMARY 
 Asymptomatic bacteriuria has been demonstrated in type 1 and 
type 2 diabetes mellitus, however the prevalence varied in different 
series. Paucity of prospective studies from India made to initiate one such 
work in this part of the country. The aims and objectives were to find out 
the prevalence of asymptomatic bacteriuria in type 2 diabetic women, to 
analyse the spectrum of organisms and its drug sensitivity pattern, to 
correlate asymptomatic bacteriuria with patient status and to design an 
algorythm to detect and manage asymptomatic bacteriuria in diabetic 
women. 
 A rigid criteria was adopted to select and assess asymptomatic 
bacteriuria among 164 type 2 diabetic individuals which was compared 
with 56 healthy individuals as control. The data were analysed 
statistically. The results of the study revealed that asymptomatic 
bacteriuria was present among 22.56% diabetic women. It was 
independent of the patients age and duration of disease. However it was 
significantly more among diabetics than control. The observation of this 
study was comparable with published reports. 
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 Among the complications, patients with nephropathy were more 
susceptible for asymptomatic bacteriuria (p<0.001). Gram negative 
organisms were more common than gram positive ones. Among the 
laboratory investigations, leucocyturia was found to be significantly 
associated with asymptomatic bacteriuria and recommended as an early 
marker to pickup asymptomatic bacteriuria even at primary health care 
level. 
ABBREVIATIONS 
ADA   : American Diabetes Association 
ASB   : Asymptomatic bacteriuria 
BMI   : Body mass index 
CVS   : Cardiovascular system 
CNS   : Central nervous system 
cfu   : Colony forming units 
C/S   : Culture and sensitivity 
DM   : Diabetes mellitus 
GFR   : Glomerular filtration rate 
HbA1C  : Haemoglobin A1C 
hpf   : High power field 
n   : Number 
NT   : Not tested 
OGTT   : Oral glucose tolerance test 
PMNLs  : Polymorphonuclear leucocytes 
PVD   : Peripheral vascular disease 
SD   : Standard deviation 
UTI   : Urinary tract infections 
WHO   : World Health Organisation 
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